Centessa Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 796 $12.82 $10,205
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 33,530 $12.82 $429,855
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 796 $12.82 $10,205
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 33,530 $12.82 $429,855
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 1,399 $12.62 $17,655
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 58,905 $12.62 $743,381
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 1,399 $12.62 $17,655
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 58,905 $12.62 $743,381
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 855 $11.62 $9,935
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 35,992 $11.62 $418,227
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 855 $11.62 $9,935
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 35,992 $11.62 $418,227
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 1,315 $11.7 $15,385
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 55,391 $11.7 $648,075
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 1,315 $11.7 $15,385
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 55,391 $11.7 $648,075
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 274 $11.34 $3,106
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 11,543 $11.34 $130,840
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 274 $11.34 $3,106
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 11,543 $11.34 $130,840
Purchase
KANTOFF AARON director
 Ordinary Shares 10,000 $11.99 $119,850
Purchase
SAHA SAURABH director, officer: Chief Execut..
 Ordinary Shares 23,000 $12.28 $282,463
Purchase
BUSH TIA L officer: Chief Quality Officer
 Ordinary Shares 4,005 $12.55 $50,263
Purchase
BUSH TIA L officer: Chief Quality Officer
 Ordinary Shares 995 $12.1 $12,040
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 586,077 $20 $11,721,540
Purchase
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10 percent owner
 Ordinary Shares 13,923 $20 $278,460
Purchase
THORELL MARELLA officer: Chief Accounting Officer
 Ordinary Shares 1,000 $20 $20,000
Purchase
WEINHOFF GREGORY M officer: Chief Financial Officer
 Ordinary Shares 10,000 $20 $200,000
Purchase
GAP (BERMUDA) LTD 10 percent owner
 ADSs 1,500,000 $20 $30,000,000
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 13,923 $20 $278,460
Purchase
DE RUBERTIS FRANCESCO director
 Ordinary Shares 586,077 $20 $11,721,540
Purchase
CHAO DAVID M officer: Chief Administrative O..
 Ordinary Shares 500 $20 $10,000
Purchase
BUSH TIA L officer: Chief Quality Officer
 Ordinary Shares 3,000 $20 $60,000
Purchase
TEMPLEMAN THOMAS officer: Chief Technology Officer
 Ordinary Shares 250 $20 $5,000
Purchase
HUSSAIN IQBAL J officer: General Counsel
 Ordinary Shares 5,500 $20 $110,000
Purchase
HUSSAIN IQBAL J officer: General Counsel
 Ordinary Shares 3,000 $20 $60,000
Purchase
GOYAL ARJUN director
 Ordinary Shares 20,250 $20 $405,000
Purchase
GOYAL ARJUN director
 Ordinary Shares 729,750 $20 $14,595,000

Showing 100 to 138 of 138 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: